Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Dornan currently holds 282,340 shares of Elevation Oncology, Inc. (ELEV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Dornan has been a net neutral trader of ELEV stock. They have purchased $0 and sold $0 worth of shares.
David Dornan's most recent insider trade was on Apr 1, 2026, when they sold 282,340 shares at $0.00 per share.
David Dornan serves as Executive at Elevation Oncology, Inc. (ELEV). They have executed 3 insider transactions totaling $0 over their tenure at the company.
David Dornan holds the position of Executive at Elevation Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
David Dornan has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by David Dornan was on Apr 1, 2026, when they purchased $0 worth of WHWK shares. This transaction involved 282,340 shares at N/A per share.
David Dornan currently owns 282,340 shares of Elevation Oncology, Inc. (ELEV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Dornan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Dornan has 3 Form 4 filings on record as an insider at Elevation Oncology, Inc..
Set alerts for David Dornan and 40,000+ other insiders.